Managing outpatient asthma exacerbations

Current Allergy and Asthma Reports

Volumn 3, Issue 2, 2003, Pages 179-189

  Roy, Sitesh R ^a   Milgrom, Henry ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOPHYLLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FENOTEROL; FORMOTEROL; HELIOX; IPRATROPIUM BROMIDE; ISOPRENALINE; LEVALBUTEROL; MAGNESIUM SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; SALBUTAMOL; SALMETEROL; ZAFIRLUKAST;

AIRWAY OBSTRUCTION; ALLERGY; ANXIETY DISORDER; ASTHMA; BETA ADRENERGIC STIMULATION; BRONCHOSPASM; CLINICAL TRIAL; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG INDUCED DISEASE; DRUG MECHANISM; FOLLOW UP; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE ISCHEMIA; HOME CARE; HUMAN; HYPERCAPNIA; HYPOKALEMIA; HYPOTENSION; LONG TERM CARE; METERED DOSE INHALER; OUTPATIENT CARE; PATIENT ATTITUDE; PATIENT COMPLIANCE; RELAPSE; REVIEW; TACHYCARDIA; TREATMENT PLANNING; TREMOR; VOCAL CORD; VOMITING; ACUTE DISEASE; ALGORITHM; AMBULATORY CARE; CLINICAL PRACTICE; EMERGENCY HEALTH SERVICE; RISK FACTOR; UNITED STATES;

ACUTE DISEASE; ALGORITHMS; AMBULATORY CARE; ASTHMA; EMERGENCY SERVICE, HOSPITAL; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS; UNITED STATES;

EID: 0037529433     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-003-0032-7     Document Type: Review

References (53)

1. Mannino DM, Homa DM, Akinbami LJ, et al.: Surveillance for asthma-United States, 1980-1999. MMWR 2002, 51:1-14.
2. Scarfone RJ, Zorc JJ, Capraro GA: Patient self-management of acute asthma: adherence to National Guidelines a decade later. Pediatrics 2001, 108:1332-1338.
3. Warman KL, Silver EJ, McCourt MP, Stein REK: How does home management of asthma exacerbations by parents of inner-city children differ from NHLBI guideline recommendations. Pediatrics 1999, 103:422-427.
4. Green RM, Custovic A, Sanderson G, et al.: Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002, 324:1-5.
5. McFadden ER Jr, Hejal RB: The pathobiology of acute asthma. Clin Chest Med 2000, 21:213-224.
6. Milgrom H, Wood RP II, Ingram D: Respiratory conditions that mimic asthma. Immunol Allergy Clin North Am 1998, 18: 13-132.
7. National Heart, Lung and Blood Institute: National Asthma Education and Prevention Program, Expert Panel Report 2: guidelines for the diagnosis and management of asthma, 1997. NIH Publication No. 97-4051A:42-43.
8. National Heart, Lung and Blood Institute: NHLBI/WHO workshop report: global strategy for asthma management and prevention. 1995, NIH Publication 96-3659. Revised 2002. p.134-135 Available at www.ginasthma.com.
9. Idris AH, McDermott MF, Raucci JC, et al.: Emergency department treatment of severe asthma, metered dose inhaler is equivalent in effectiveness to nebulizer. Chest 1993, 103:665-672.
10. Closa RM, Ceballos JM, Fomez-Papi A, et al.: Efficacy of bronchodilators administered by nebulizers versus spacer devices in infants with acute wheezing. Pediatr Pulmonol 1998, 26:344-348.
11. Cates CJ, Rowe BH, Bara A: Holding chambers versus nebulizers for beta-agonist treatment of acute asthma. In The Cochrane Database of Systematic Reviews. Issue 2:2002.
12. Beasley R, Crane J, Buress C: b-agonists: What is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol 1999, 103:S18-30.
13. Templeton AGB, Chapman I, Chilvers E, et al.: Effects of S-salbutamol on isolated human bronchus. Pulm Pharmacol Ther 1998, 11:1-6.
14. Baramki D, Koester J, Anderson AJ, Borish L: Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S -isomer. J Allergy Clin Immunol 2002, 109:449-454.
15. Cockcroft DW, Davis BE, Swystun VA, et al.: Tolerance to the bronchoprotective effect of Β2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo. J Allergy Clin Immunol 1999, 103:1049-1053.
16. Lotvall J, Palmqvist M, Arvidsson P, et al.: The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients. J Allergy Clin Immunol 2001, 108: 26-731.
17. Ahrens R, Weinberger M: Levalbuterol and racemic albuterol: Are there therapeutic differences? J Allergy Clin Immunol 2001, 108:681-684.
18. Milgrom H, Skoner DP, Bensch G, et al.: Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol. J Allergy Clin Immunol 2001, 108:938-945.
19. Nelson HS, Bensch G, Pleskow WW, et al.: Improved bronchodilation with levalbuterol compared to racemic albuterol in patients with asthma. J Allergy Clin Immunol 1998, 102: 43-952.
20. Selroos O: Formoterol used as needed: clinical effectiveness. Resp Med 2001, 95(suppl B):S17-S20.
21. Geelhoed GC, Landau LI, LeSouef PN: Evaluation of SaO2 as a predictor of outcome in 280 children presenting with acute asthma. Ann Emerg Med 1994, 23:1236-1241.
22. Chien JW, Ciufo R, Novak R, et al.: Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest 2000, 117:728-733.
23. Rowe BH, Spooner C, Ducharme FM, et al.: Early emergency department treatment of acute asthma with systemic corticosteroids. In Cochrane Database of Systematic Reviews. Issue 2:2002.
24. Ratto D, Alfaro C, Sipsey J, et al.: Are intravenous corticosteroids required in status asthmaticus. JAMA 1988, 260:527-529.
25. O'Driscoll BR, Karla S, Wison M, et al.: Double blind trial of steroid tapering in acute asthma. Lancet 1993, 341:324-327.
26. Rowe BH, Spooner CH, Ducharme FM, et al.: Corticosteroids for preventing relapse following acute exacerbations of asthma. In The Cochrane Database of Systematic Reviews. Issue 2:2002.
27. Rodrigo G, Rodrigo C: Inhaled flunisolide for acute severe asthma. Am J Resp Crit Care Med 1998, 157:698-703.
28. Volvovitz B, Bentur L, Finkelstein Y, et al.: Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol 1998, 102:605-609.
29. Schuh S, Reisman J, Alshehri M, et al.: A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med 2000, 343:689-694.
30. Edmonds ML, Camargo Jr CA, Pollack CV Jr, Rowe BH: Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. In The Cochrane Database Systematic Reviews. Issue 2:2002.
31. Rowe BH, Bota GW, Fabris L, et al.: Inhaled budesonide in addition to oral corticosteroids to prevent relapse following discharge from the emergency department: a randomized controlled trial. JAMA 1999, 281:2119-2126.
32. Qureshi F, Pestian J, Darius P, Zaritsky A: Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 1998, 339:1030-1035.
33. Rodrigo GJ, Rodrigo C: First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 2000, 161:1862-1868.
34. Stoodley RG, Aaron SD, Dales RE: The role of ipratropium bromide in the emergency management of acute asthma exacerbation: meta-analysis of randomized clinical trials. Ann Emerg Med 1999, 34:8-18.
35. Rowe BH, Bretzlaff JA, Bourdon C, et al.: Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. In The Cochrane Database of Systematic Reviews. Issue 2:2002.
36. Parameshwaran K, Belda J, Rowe BH: Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. In The Cochrane Database of Systematic Reviews. Issue 2:2002.
37. Travers A, Jones AP, Kelly K, et al.: Intravenous beta2-agonists for acute asthma in the emergency department. In The Cochrane Database of Systematic Reviews. Issue 2:2002.
38. Rodrigo G, Rodrigo C, Pollack C, Rowe B: Helium-oxygen mixture for non-intubated acute asthma patients. In The Cochrane Database of Systematic Reviews. Issue 2:2002.
39. Kress JP, Noth I, Gehlbach BK, et al.: The utility of albuterol nebulized with heliox during acute asthma exacerbations. Am J Resp Crit Care Med 2002, 165:1317-1321.
40. Garrett J, Williams S, Wong C, Holdaway D: Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid. Arch Dis Child 1998, 79:12-17.
41. McFadden ER Jr, Elsanadi N, Dixon L, et al.: Protocol therapy for acute asthma: therapeutic benefits and cost savings. Am J Med 1995, 99:651-661.
42. Shreshta M, Bidadi K, Gourlay S, Hayes J: Continuous versus intermittent albuterol at high and low doses in the treatment of acute severe asthma in adults. Chest 1996, 110:42-47.
43. Schuh S, Parkin P, Rajan A, et al.: High versus low dose, frequently administered nebulized albuterol in children with severe acute asthma. Pediatrics 1989, 83:513-518.
44. Emerman CL, Cydulka RK: Factors associated with relapse after emergency department treatment of acute asthma. Ann Emerg Med 1995, 26:6-11.
45. Emerman CL, Woodruff PG, Cydulka RK, et al.: Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department. Chest 1999, 115:919-927.
46. Marquette CH, Saulnier F, Leroy O, et al.: Long term prognosis of near fatal asthma: a 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Resp Dis 1992, 46:76-81.
47. Magadle R, Berar-Yanay N, Weiner P: The risk of hospitalization and near-fatal and fatal asthma in relation to perception of dyspnea. Chest 2002, 121:329-333.
48. Suissa S, Blais L, Ernst P: Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma. EUT Resp J 1994, 7:1602-1609.
49. Newman KB, Mason UG, Schmaling KB: Clinical features of vocal cord dysfunction. Am J Resp Crit Care Med 1995, 152: 382-1386.
50. Wood RP 2nd, Milgrom H: Vocal cord dysfunction. J Allergy Clin Immunol 1996, 98:481-485.
51. Mak H, Johnston P, Abbey H, et al.: Prevalence of asthma and health service utilization of asthmatic children in an inner city. J Allergy Clin Immunol 1982, 70:367-372.
52. Park CL, Frank AL, Sullivan M, et al.: Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 1996, 98(2 pt 1 ):196-200.
53. Lieu TA, Quesenberry CP, Capra M, et al.: Outpatient management practices associated with reduced risk of pediatric asthma hospitalization and emergency department visits. Pediatrics 1997, 100:334-341.